{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:28:11Z","timestamp":1793039291261,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014569","name":"Spanish Society of Hospital Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.farma.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:23:05Z","timestamp":1774560185000},"page":"294-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis"],"prefix":"10.1016","volume":"50","author":[{"given":"Gabriel","family":"Mercadal-Orfila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piedad","family":"L\u00f3pez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Padull\u00e9s-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00e1nzazu","family":"Pou Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Ibarra-Barrueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Monte-Boquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Borr\u00e1s Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sanmartin-Fenollera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Capilla Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Angeles","family":"Bernab\u00e9u Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Notario Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Escriv\u00e1 Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Herrera-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2026.01.006_bb0005","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2026.01.006_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1465725","article-title":"TELEPROM psoriasis: enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis","volume":"11","author":"Mercadal-Orfila","year":"2024","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.farma.2026.01.006_bb0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalencia de la psoriasis en Espa\u00f1a en la era de los agentes biol\u00f3gicos","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.farma.2026.01.006_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12955-024-02312-4","article-title":"The use of patient-reported outcome measures to improve patient-related outcomes \u2013 a systematic review","volume":"22","author":"Bonsel","year":"2024","journal-title":"Health Qual Life Outcomes"},{"issue":"23","key":"10.1016\/j.farma.2026.01.006_bb0025","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.3390\/jcm12237215","article-title":"Aging impact in response to different classes of biological treatment in psoriatic patients: a real-life observational study","volume":"12","author":"Rosset","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.farma.2026.01.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002533","article-title":"Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study","volume":"9","author":"Tillett","year":"2023","journal-title":"RMD Open"},{"issue":"7416","key":"10.1016\/j.farma.2026.01.006_bb0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.327.7416.634","article-title":"Immunomodulatory drugs for psoriasis","volume":"327","author":"Boehncke","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.farma.2026.01.006_bb0040","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.42441","article-title":"Sex differences in dermatology life quality index (DLQI) among patients with psoriasis","volume":"104","author":"Jensen","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.farma.2026.01.006_bb0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jdv.14910","article-title":"Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: results from the randomized VOYAGE 1 trial","volume":"32","author":"Papp","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.farma.2026.01.006_bb0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13555-021-00511-1","article-title":"Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe plaque psoriasis: a network meta-analysis","volume":"11","author":"Armstrong","year":"2021","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.farma.2026.01.006_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40265-024-02028-1","article-title":"Drug survival of IL-17 and IL-23 inhibitors for psoriasis: a systematic review and meta-analysis","volume":"84","author":"Thomas","year":"2024","journal-title":"Drugs"},{"issue":"S1","key":"10.1016\/j.farma.2026.01.006_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ajd.14497","volume":"66","author":"Biologics\/Psoriasis","year":"2025","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.farma.2026.01.006_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/PTT.S534881","article-title":"Beyond skin clearance: personalized strategies for DLQI improvement in psoriasis -insights from a Shanghai prospective cohort","volume":"15","author":"Ma","year":"2025","journal-title":"Psoriasis Targets Ther"},{"key":"10.1016\/j.farma.2026.01.006_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1654343","article-title":"Efficacy and safety of IL-17, IL-12\/23, and IL-23 inhibitors for psoriatic arthritis: A network meta-analysis of randomized controlled trials","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.farma.2026.01.006_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1332432","article-title":"Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients","volume":"10","author":"Lo Monaco","year":"2024","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.farma.2026.01.006_bb0080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2023.5439","article-title":"Patient-reported outcome measures for health-related quality of life in patients with psoriasis: a systematic review","volume":"160","author":"P\u00e9rez-Chada","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.farma.2026.01.006_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1997.tb14934.x","article-title":"Quality of life measurement in dermatology: a practical guide","volume":"136","author":"Finlay","year":"1997","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.farma.2026.01.006_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0001-7310(09)70821-X","article-title":"Consensus document on the evaluation and treatment of moderate to severe psoriasis. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology","volume":"100","author":"Puig","year":"2009","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas Engl Ed"},{"issue":"4","key":"10.1016\/j.farma.2026.01.006_bb0095","first-page":"174","article-title":"Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: recommendations for its implementation and development","volume":"44","author":"Morillo-Verdugo","year":"2020","journal-title":"Farm Hosp"},{"key":"10.1016\/j.farma.2026.01.006_bb0100","series-title":"Gu\u00eda MAPEX de implantaci\u00f3n y uso de PROMs y PREMs en la atenci\u00f3n farmac\u00e9utica en consulta externa de farmacia hospitalaria.","author":"Sociedad Espa\u00f1ola de Farmacia Hospitalaria (SEFH)","year":"2024"},{"key":"10.1016\/j.farma.2026.01.006_bb0105","doi-asserted-by":"crossref","DOI":"10.2196\/56196","article-title":"Implementing systematic patient-reported measures for chronic conditions through the naveta value-based telemedicine initiative: observational retrospective multicenter study","volume":"12","author":"Mercadal-Orfila","year":"2024","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"10.1016\/j.farma.2026.01.006_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjd.16809","article-title":"Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16545 biologic-na\u00efve patients from the French National Health Insurance database (SNIIRAM)","volume":"180","author":"Sbidian","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.farma.2026.01.006_bb0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/jdv.13990","article-title":"Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two phase III randomized studies","volume":"31","author":"Gottlieb","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.farma.2026.01.006_bb0120","article-title":"Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists","volume":"9","author":"Gonzalez-Cantero","year":"2023","journal-title":"Int J Women's Dermatol"},{"issue":"2","key":"10.1016\/j.farma.2026.01.006_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/jpm14020186","article-title":"Effectiveness and safety of biological therapies in very severe plaque psoriasis: a real-life retrospective study","volume":"14","author":"Fiorillo","year":"2024","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.farma.2026.01.006_bb0130","first-page":"36","article-title":"Implementation and evaluation of a home pharmaceutical care model through telepharmacy","volume":"46","author":"Villanueva-Bueno","year":"2022","journal-title":"Farm Hosp"},{"issue":"1","key":"10.1016\/j.farma.2026.01.006_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/135763303321159684","article-title":"Patient satisfaction with teledermatology services","volume":"9","author":"Hicks","year":"2003","journal-title":"J Telemed Telecare"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:48:23Z","timestamp":1788032903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1130634326000097"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.01.006","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}